# Stefan Linn

> Stefan Linn is a Miami-based investor and operating executive, serving as Managing Partner and CEO of L1 Health since 2020. His career includes leadership positions at McKesson, TPG Capital, IMS Health and Oxford Immunotec, alongside an executive chair role at Remedica. His documented work spans franchise development, acquisitions, commercial operations and investment in manufacturing infrastructure.

- **Role:** Managing Partner & CEO at L1 Health
- **Organizations:** LetterOne, L1 Health, Remedica, Destination Pet, Oxford Immunotec, IMS Health, TPG Capital, McKesson, Health Mart, Merck-Medco, Systemed, McKinsey & Company
- **Education:** BA in Economics, University of Dallas, MBA, University of California, Berkeley
- **Known for:** Led Health Mart during its July 2006 franchise relaunch and subsequent expansion., Held senior responsibilities spanning strategy, acquisitions and commercial operations at IMS., Has led L1 Health as Managing Partner and CEO since 2020.

## Career timeline

- **1996-2001** — Vice President of Marketing at Merck-Medco.
- **2001-2007** — Senior Vice President at McKesson; also served as President of Health Mart.
- **2006** — Health Mart relaunched in July under his presidency.
- **2008-2010** — Director at TPG.
- **2010** — Joined IMS as Senior Vice President, Strategy and Business Development in October.
- **2011** — Became Senior Vice President, Strategy, Innovation and Development at IMS in January.
- **2012** — Became Senior Vice President, Strategy and Global Pharma Solutions at IMS in September.
- **2017** — Joined Oxford Immunotec as Chief Operating Officer in August.
- **2019** — Signed a supply-chain cooperation agreement with Shanghai Pharmaceuticals Holdings in November.
- **2020** — Left Oxford Immunotec effective April 15; became Managing Partner and CEO of L1 Health that year.
- **2024** — Spoke as Remedica Executive Chair at the July logistics-centre opening in Limassol.

## Achievements

- Led Health Mart during its July 2006 franchise relaunch and subsequent expansion.
- Held senior responsibilities spanning strategy, acquisitions and commercial operations at IMS.
- Has led L1 Health as Managing Partner and CEO since 2020.

## Latest updates

- **2025-11** — Listed as a speaker and opening-remarks presenter in the L1 Health Summit 2025 programme.
- **2024-09** — Discussed capital commitments, operations and staff development in a published interview as Remedica Executive Chair.
- **2024-07** — Spoke at Remedica’s new logistics-centre opening in Limassol.

## Links

- Website: https://letterone.com/our-businesses/business-units-people/stefan-linn/
- LinkedIn: https://www.linkedin.com/in/stefanlinn

---

Profile page: https://yespress.io/stefan-linn
Published by YesPress — https://yespress.io
Last updated: 2026-10-10